Director Of Commercial Development, Drug Product
CurrentIn this role, I spearhead the development, rollout, and execution of our commercial and businessstrategy for the Drug Product business unit. I collaborate with Sales on defending new business proposals and bids; monitor capabilities and the competitive landscape to prepare both the organization and individual sites for scale; and identify opportunities to resolve gaps through business development, expansion, and M&As.Selected Accomplishments:• Navigated a large-scale organizational transformation and change as a pharma manufacturingsite acquisition was converted to a CDMO within the first few months of my tenure, leading theintegration for all of 2023. As a result of my efforts, we saw attainment of our continuous growthtargets, as well as the enhancement of our site culture to align with our long-term business visionand the CDMO operating model.• Named the Key Commercial Lead on due diligence of a new fill/finish site acquisition, as well asdirected Capex programs to extend our new site’s capabilities and provided commercialjustification for spend.• Partnered with the Chief Commercial Officer on successfully securing four new commercial techtransfer projects valued at more than $1B, positioning our team to achieve the #1 position in thecompany for revenue attainment.• Collaborated with site-based Supply Chain and Finance teams to refine our operating and costmodels inclusive of manufacturing schedules, delivery practices, invoicing policies, and revenuerecognition.• Served as the Subject Matter Expert (SME) on the marketing plan, strategy, and content forResilience DP offerings, developing creative content for the launch of new website, presentations,e-books, and more.